Granulocytopoesis under conditions of cytostatic treatment for non-small cell lung cancer
Changes in granulocytopoesis were studied in patients with III-IV stage non small cell lung cancer who received cytostatic treatment with docetaxel/cisplatin regimen as compared to combination of cyclophosphamide/vincristin/carboplatin. Granulocytopoesis under conditions of cytostatic treatment with docetaxel/cisplatin was shown to be able to compensate damages induced by cytostatic agents, that was detected on the levels of committed precursors, morphologically differentiated elements of the marrow and peripheral blood.